Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing vascular inflammation in large vessel vasculitis using advanced imaging techniques

Official title: A Prospective, Observational Study on Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis(LVV) Based on PET/MRA Image Evaluation System

Run by Nanjing Medical University · NCT06824714 · Data updated 2026-11-12

This study is testing advanced imaging techniques to see how well they can identify inflammation in the blood vessels of people with large vessel vasculitis to help guide their treatment.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorNanjing Medical University
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedJanuary 1, 2028
Study endsJuly 1, 2028
Registry record updatedFebruary 13, 2025
Trial IDNCT06824714 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with clinically suspected or confirmed large vessel vasculitis who are willing to undergo PET/MRA imaging.

Probably not a fit

Patients with other serious cardiovascular or cerebrovascular diseases, severe mental disorders, or those who cannot undergo the required imaging due to medical devices or allergies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate vascular wall inflammation in patients diagnosed with large vessel vasculitis (LVV) through the use of positron emission tomography and magnetic resonance imaging (PET/MRA). Participants will undergo a baseline clinical assessment, laboratory tests, and PET/MRA imaging, followed by a treatment protocol determined by clinicians. The study includes a 12-month follow-up period with clinic visits every 1-2 months for ongoing assessments and re-examinations. The goal is to improve the identification of vascular inflammation to guide treatment decisions effectively.

Why it matters

Potential benefit: If successful, this study could enhance the ability to detect vascular inflammation in LVV, leading to timely and more effective treatment options for patients.

How similar studies have gone: While this approach is innovative, similar studies utilizing advanced imaging techniques for vascular inflammation assessment have shown promise in other conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Clinically suspected or confirmed LVV and willing to undergo PET/MRA
2. Compliance with long-term follow-up
3. Sign informed consent.

Exclusion Criteria:

1. Patients with other serious cardiovascular and cerebrovascular diseases, malignant tumors, infectious diseases, severe renal insufficiency.
2. Severe mental disorders, severe claustrophobia unable to cooperate with the examination.
3. Patients equipped with cardiac pacemaker, artificial heart valve, ferromagnetic vascular clamp after vascular surgery, aneurysm clamp, artificial cochlea, insulin pump and other drug dosage control devices, steel nail plate and other metal internal fixation, artificial joint, electronic eye, artificial eye.
4. Allergic to contrast medium.
5. Pregnant or lactating women.

Withdrawal criteria:

1. Any exclusion criteria emerged during patient follow-up.
2. Voluntarily withdrew from the study.

Where it's running

  • Department of Rheumatology and Immunology, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.